Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2017
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Antineoplastic Agents, Hormonal (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Premenopause (MeSH)